BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-35 Cr | ₹4.87 Cr | ₹6.08 Cr | ₹34 Cr | ₹0.00 Cr |
What is the latest Cash Flow from Operating Activities ratio of BALAXI PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-35 Cr |
| Mar2024 | ₹4.87 Cr |
| Mar2023 | ₹6.08 Cr |
| Mar2022 | ₹34 Cr |
| Mar2021 | ₹0.00 Cr |
How is Cash Flow from Operating Activities of BALAXI PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-35 Cr | Negative | |
| Mar2024 | ₹4.87 Cr | -19.90 | |
| Mar2023 | ₹6.08 Cr | -82.21 | |
| Mar2022 | ₹34 Cr | 1,138,066.67 | |
| Mar2021 | ₹0.00 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹97.5 Cr | -11.9% | -19.5% | -74.3% | Stock Analytics | |
| ADANI ENTERPRISES | ₹255,382.0 Cr | -1.1% | -10.7% | -9.3% | Stock Analytics | |
| REDINGTON | ₹18,207.5 Cr | -10% | -12.2% | -4.4% | Stock Analytics | |
| HONASA CONSUMER | ₹8,671.1 Cr | -7.9% | -10.9% | 23.9% | Stock Analytics | |
| MMTC | ₹7,876.5 Cr | -6.2% | -19.9% | 1.1% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹6,991.6 Cr | -7.1% | -20.3% | 22.3% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -11.9% |
-19.5% |
-74.3% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses